Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 91
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00978575 | Iron Substitution After Upper Gastro-Intestinal Bleeding | ||
| NCT01101399 | Ferric Carboxymaltose in Subjects With Functional Iron Deficiency Undergoing Chemotherapy | ||
| NCT03574311 | Preoperative Intravenous Ferric Carboxymaltose and Placebo in the Treatment of Patients Undergoing Cardiac Surgery | ||
| NCT01477424 | A Drug-Drug Interaction Study of Warfarin and PA21 | ||
| NCT01245777 | Restless Legs Syndrome With Iron Deficiency or Anaemia in the 3rd Trimester of Pregnancy | ||
| NCT01452906 | A Drug-Drug Interaction Study of Omeprazole and PA21 | ||
| NCT05077436 | Bioavailability Study Comparing 2 Vamifeport Oral Formulations in Fasted Versus Fed State in Healthy Subjects | ||
| NCT05460234 | RAYALDEE Non Interventional Study (NIS) on Effectiveness in ND-CKD SHPT Patients | ||
| NCT05897684 | Avacostar - (PASS) | ||
| NCT02937454 | Study to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron Deficiency | ||
| NCT04864795 | Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalaemia or at High Risk of Hyperkalaemia | ||
| NCT01324128 | A Phase 3 Study to Investigate the Safety and Efficacy of PA21, a Phosphate Binder, in Dialysis Patients | ||
| NCT00810030 | FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR | ||
| NCT01810939 | A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia (OPAL) | ||
| NCT05415969 | CKD-aP Among Adults on Dialysis in Switzerland | ||
| NCT01438359 | A Drug-Drug Interaction Study of Furosemide and PA21 | ||
| NCT00414128 | Clinical Trial of Mycophenolate Versus Cyclophosphamide in ANCA Vasculitis | ||
| NCT05786469 | Patiromer Trial in CKD Stage IIIB to V | ||
| NCT04903717 | Pragmatic Trial Of Alerts for Use of Mineralocorticoid Receptor Antagonists | ||
| NCT02033317 | An Open-Label, Multiple Dose Study to Evaluate the Pharmacology, Safety, and Tolerability of Patiromer in Participants on Hemodialysis | ||
| NCT01057004 | EVIdence Based TreAtment - Heart Failure (EVITA-HF) | ||
| NCT02688764 | A Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia | ||
| NCT03957187 | Prevalence and Clinical Associates of Iron Deficiency in Patients With Atrial Fibrillation | ||
| NCT02147795 | The German Patient Blood Management Network | ||
| NCT01324752 | A Drug-Drug Interaction Study of Losartan and PA21 | ||
| NCT03214627 | Artificial Intelligence for Optimal Anemia Management in End-stage Renal Disease: The Anemia Control Model (ACM) Trial | ||
| NCT05766839 | Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age | ||
| NCT02221752 | Impact of Iron/Folic Acid vs Folic Acid Supplements During Pregnancy on Maternal and Child Health | ||
| NCT06593392 | Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus | ||
| NCT03071263 | Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease | ||
| NCT03781089 | Patiromer Efficacy to Reduce Episodic Hyperkalemia in End Stage Renal Disease Patients | ||
| NCT01219309 | Omega-3/Omega-6 Fatty Acids for Attention-Deficit/Hyperactivity Disorder (ADHD): A Trial in Children and Adolescents | ||
| NCT06434025 | IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency | ||
| NCT00824460 | Study of Phosphate Levels in Patients With Chronic Kidney Disease | ||
| NCT01453608 | A Study to Compare the Use of Ferric Carboxymaltose With Placebo in Patients With Chronic Heart Failure and Iron Deficiency | ||
| NCT04806048 | Feasibility of Implementation of Recommended Standards in Patients With Heart Failure | ||
| NCT04249648 | Hyperkalaemia and Its Impact on Therapy with RAASi | ||
| NCT02557477 | Omega 3/6 Fatty Acids for Reading in Children | ||
| NCT00746551 | Intravenous Versus Oral Iron in Late Pregnancy: Results of Treatment | ||
| NCT01394562 | Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Iron Deficiency and Chronic Heart Failure | ||
| NCT02243735 | Trial Comparing Ferric(III)Carboxymaltose Infusion With Oral Iron Suppletion as Treatment of Anaemia | ||
| NCT00810004 | Maintenance Treatment of Iron Deficiency in IBD Patients | ||
| NCT05885763 | Pharmacokinetics of Intravenous Difelikefalin in Chinese Adult Subjects on Haemodialysis | ||
| NCT01371747 | Patiromer in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic Nephropathy (AMETHYST-DN) | ||
| NCT03010072 | The Effect of Phosphate Lowering Using Sucroferric Oxyhydroxide (PA21) on Calcification Propensity of Serum | ||
| NCT04364269 | Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Preliminary Efficacy of VIT-2763 in β-thalassaemia | ||
| NCT05885737 | Phase 3 Study of Difelikefalin in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus | ||
| NCT01513369 | Ferric Carboxymaltose in Type 2 Diabetes Mellitus (T2DM) Patients With Iron Deficiency | ||
| NCT04938635 | Efficacy and Safety Study of Multiple Doses of VIT-2763 in Adults With Transfusion-dependent Beta-thalassemia | ||
| NCT02125344 | A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto) |
